Incentive Spirometer and Inspiratory Muscle Trainer

Sponsor
King Saud University (Other)
Overall Status
Completed
CT.gov ID
NCT05201742
Collaborator
(none)
18
1
2
15
1.2

Study Details

Study Description

Brief Summary

Patients suffering from parkinsonism have respiratory function abnormalities. This study compared the effects of incentive spirometer and inspiratory muscle trainer on pulmonary functions in patients with parkinsonism.

Condition or Disease Intervention/Treatment Phase
  • Other: Inspiratory muscle training
  • Other: Incentive Spirometry
N/A

Detailed Description

The participants were recruited according to the inclusion and exclusion criteria. Participants were divided into two groups - incentive spirometer and inspiratory muscle trainer. These trainings were performed for 6 weeks duration. Several outcome measures related to pulmonary function tests were measured before and after the intervention.

Study Design

Study Type:
Interventional
Actual Enrollment :
18 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Comparative Study of Incentive Spirometer Versus Inspiratory Muscle Trainer on Pulmonary Function in Patients With Parkinsonism
Actual Study Start Date :
Feb 6, 2017
Actual Primary Completion Date :
Jan 18, 2018
Actual Study Completion Date :
May 10, 2018

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Inspiratory muscle trainer

Inspiratory muscle trainer group - Inspiratory muscle training was performed.

Other: Inspiratory muscle training
Threshold inspiratory muscle training was performed for 6 weeks with device.

Active Comparator: Incentive spirometer

Incentive spirometer group - Incentive spirometry was performed.

Other: Incentive Spirometry
Incentive spirometry was performed for 6 weeks with device.

Outcome Measures

Primary Outcome Measures

  1. Maximum inspiratory pressure (MIP) [6 weeks]

    Maximum inspiratory pressure was measured.

  2. 6-minute walk distance (6 MWD) [6 weeks]

    Distance walked by the patients in 6 minutes was measured.

  3. Forced vital capacity (FVC) [6 weeks]

    Forced vital capacity was measured.

  4. Forced expiratory volume in 1 second (FEV1) [6 weeks]

    Forced expiratory volume in 1 second was measured

  5. Peak Expiratory Flow Rate (PEFR) [6 weeks]

    Peak Expiratory Flow Rate was measured

Eligibility Criteria

Criteria

Ages Eligible for Study:
65 Years to 75 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients diagnosed as having Parkinsonism Disease by the Neuro physician.

  • Duration of Parkinson's Disease ≥ 5 years.

  • Patients with the age of 65 to 80 years.

  • Hoen and Yahr classification within 1 to 3.

  • Both males and females were included.

  • Patients who were able to comprehend the commands.

  • Patients who were willing to participate.

Exclusion Criteria:
  • Patients having any cardiovascular and pulmonary disorders.

  • History of smoking currently or in the past.

  • Psychological Impairment.

  • Insufficient verbal/intellectual understanding.

  • Patients with unstable vital parameters.

  • Those unable to perform pulmonary function tests (PFT) because of anatomical abnormalities or clinical signs of dementia.

Contacts and Locations

Locations

Site City State Country Postal Code
1 King Saud University Riyadh Saudi Arabia 11433

Sponsors and Collaborators

  • King Saud University

Investigators

  • Principal Investigator: Masood Khan, M.P.Th, King Saud University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Masood Khan, Researcher, King Saud University
ClinicalTrials.gov Identifier:
NCT05201742
Other Study ID Numbers:
  • GSITESC/24/16
First Posted:
Jan 21, 2022
Last Update Posted:
Feb 10, 2022
Last Verified:
Jan 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Masood Khan, Researcher, King Saud University
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 10, 2022